Stifel Financial Corp Invests $1.26 Million in Smith & Nephew plc (NYSE:SNN)

Stifel Financial Corp acquired a new stake in shares of Smith & Nephew plc (NYSE:SNN) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 40,399 shares of the medical equipment provider’s stock, valued at approximately $1,258,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC boosted its stake in shares of Smith & Nephew by 1,894.3% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,735 shares of the medical equipment provider’s stock worth $43,000 after purchasing an additional 1,648 shares during the last quarter. GAMMA Investing LLC lifted its stake in shares of Smith & Nephew by 160.0% during the third quarter. GAMMA Investing LLC now owns 2,257 shares of the medical equipment provider’s stock valued at $70,000 after buying an additional 1,389 shares during the period. EverSource Wealth Advisors LLC boosted its position in Smith & Nephew by 92.5% during the second quarter. EverSource Wealth Advisors LLC now owns 2,454 shares of the medical equipment provider’s stock worth $61,000 after acquiring an additional 1,179 shares during the last quarter. Blue Trust Inc. grew its stake in Smith & Nephew by 460.5% in the 3rd quarter. Blue Trust Inc. now owns 4,658 shares of the medical equipment provider’s stock worth $145,000 after acquiring an additional 3,827 shares during the period. Finally, Coerente Capital Management acquired a new position in Smith & Nephew in the 3rd quarter valued at $202,000. Hedge funds and other institutional investors own 25.64% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on SNN shares. StockNews.com cut Smith & Nephew from a “strong-buy” rating to a “buy” rating in a report on Tuesday, November 12th. Berenberg Bank lowered Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Wednesday, November 6th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Friday, November 1st.

Smith & Nephew Stock Down 0.5 %

Shares of SNN opened at $24.66 on Monday. Smith & Nephew plc has a fifty-two week low of $23.65 and a fifty-two week high of $31.72. The company’s fifty day moving average is $26.21 and its two-hundred day moving average is $27.89. The firm has a market cap of $10.78 billion, a PE ratio of 12.58, a price-to-earnings-growth ratio of 1.41 and a beta of 0.84. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63.

Smith & Nephew Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.